RENAISSANCE TECHNOLOGIES LLC 13D and 13G filings for Celldex Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-10 4:51 pm Sale | 2020-12-31 | 13G | Celldex Therapeutics, Inc. CLDX | RENAISSANCE TECHNOLOGIES LLC | 1,048,827 2.650% | -66,541 (-5.97%) | Filing |